tiprankstipranks
Exopharm Ltd. (AU:EX1)
ASX:EX1

Exopharm Ltd. (EX1) Financial Statements

1 Followers

Exopharm Ltd. Financial Overview

Exopharm Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.011; its P/E ratio is -0.93; Exopharm Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 4.85MAU$ 12.72MAU$ 1.74MAU$ 4.42M
Total AssetsAU$ 13.61MAU$ 21.46MAU$ 6.54MAU$ 5.40M
Total DebtAU$ 3.74MAU$ 1.36MAU$ 912.87KAU$ 0.00
Net DebtAU$ -1.10MAU$ -11.37MAU$ -830.05KAU$ -4.42M
Total LiabilitiesAU$ 4.81MAU$ 2.59MAU$ 1.53MAU$ 281.00K
Stockholders EquityAU$ 8.81MAU$ 18.87MAU$ 5.02MAU$ 5.12M
Cash Flow-
Free Cash Flow----
Operating Cash Flow----
Investing Cash Flow----
Financing Cash Flow----
Currency in AUD

Exopharm Ltd. Earnings and Revenue History

Exopharm Ltd. Debt to Assets

Exopharm Ltd. Cash Flow

Exopharm Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis